We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $646M
1-Year Est. Return 43.3%
This Fund
S&P 500
This Quarter Est. Return
+5.05%
1 Year Est. Return
+43.3%
3 Year Est. Return
+98.62%
5 Year Est. Return
+125.42%
10 Year Est. Return
+408.39%
AUM
$236M
AUM Growth
+$11.3M
Cap. Flow
+$2.4M
Cap. Flow %
1.02%
Top 10 Hldgs %
32.76%
Holding
119
New
6
Increased
45
Reduced
36
Closed
15

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$916K
2
ABT icon
Abbott
ABT
+$605K
3
ROK icon
Rockwell Automation
ROK
+$566K
4
XLNX
Xilinx Inc
XLNX
+$559K
5
TGT icon
Target
TGT
+$520K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$2.61M
2
ADP icon
Automatic Data Processing
ADP
+$553K
3
XOM icon
ExxonMobil
XOM
+$394K
4
DYAX
DYAX CORPORATION
DYAX
+$376K
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$354K

Sector Composition

Rank Sector Weight
1 Technology 21.07%
2 Healthcare 20.68%
3 Industrials 19.38%
4 Energy 10.99%
5 Consumer Staples 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PG icon
1
Procter & Gamble
PG
$335B
$10.2M 4.32%
111,807
+4,765
+4% +$419K
XOM icon
2
ExxonMobil
XOM
$652B
$8.84M 3.74%
95,602
-4,225
-4% -$394K
CVS icon
3
CVS Health
CVS
$121B
$8.7M 3.68%
90,276
+4,475
+5% +$394K
JNJ icon
4
Johnson & Johnson
JNJ
$632B
$8.11M 3.44%
77,564
+2,485
+3% +$262K
MMM icon
5
3M
MMM
$94.2B
$7.72M 3.27%
56,213
+1,940
+4% +$249K
NVS icon
6
Novartis
NVS
$288B
$7.54M 3.19%
90,809
+6,054
+7% +$502K
CNI icon
7
Canadian National Railway
CNI
$76.4B
$6.88M 2.91%
99,837
+2,802
+3% +$192K
ADP icon
8
Automatic Data Processing
ADP
$110B
$6.6M 2.79%
79,123
-6,819
-8% -$553K
EMR icon
9
Emerson Electric
EMR
$91.4B
$6.19M 2.62%
100,224
+8,175
+9% +$512K
INTC icon
10
Intel
INTC
$527B
$6.17M 2.62%
170,173
+5,903
+4% +$205K
ATR icon
11
AptarGroup
ATR
$8.43B
$5.86M 2.48%
87,689
+3,175
+4% +$201K
CVX icon
12
Chevron
CVX
$388B
$5.43M 2.3%
48,369
-1,248
-3% -$142K
HD icon
13
Home Depot
HD
$341B
$5.16M 2.18%
49,102
+993
+2% +$96.5K
AAPL icon
14
Apple
AAPL
$4.46T
$5.02M 2.13%
181,812
+10,376
+6% +$282K
EMC
15
DELISTED
EMC CORPORATION
EMC
$4.5M 1.9%
151,179
+4,935
+3% +$144K
ORCL icon
16
Oracle
ORCL
$450B
$4.42M 1.87%
98,347
+1,746
+2% +$71.1K
ROK icon
17
Rockwell Automation
ROK
$50.1B
$4.32M 1.83%
38,847
+5,163
+15% +$566K
RTX icon
18
RTX Corp
RTX
$297B
$4.19M 1.77%
57,890
+1,291
+2% +$88K
PEP icon
19
PepsiCo
PEP
$192B
$4.05M 1.72%
42,878
-173
-0.4% -$16.6K
QCOM icon
20
Qualcomm
QCOM
$173B
$3.98M 1.69%
53,530
+5,655
+12% +$414K
FISV
21
Fiserv Inc
FISV
$29.5B
$3.69M 1.56%
104,058
+6,120
+6% +$210K
NXPI icon
22
NXP Semiconductors
NXPI
$58.5B
$3.51M 1.49%
45,873
+200
+0.4% +$14.2K
MA icon
23
Mastercard
MA
$497B
$3.49M 1.48%
40,505
+5,565
+16% +$454K
ABT icon
24
Abbott
ABT
$193B
$3.32M 1.41%
73,820
+13,880
+23% +$605K
HP icon
25
Helmerich & Payne
HP
$4.29B
$3.2M 1.35%
47,459
-339
-0.7% -$26.4K
1
2 3 4 5

Similar funds

HCM
Huber Capital Management El Segundo, California $647M AUM 24.91% 1-Year Est. Return
ACA
Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return
CRCM
Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return
GECH
Garnet Equity Capital Holdings New York $642M AUM 58.94% 1-Year Est. Return
APC
Alta Park Capital San Francisco, California $642M AUM 140.04% 1-Year Est. Return
WHGAM
Wealth High Governance Asset Management Sao Paulo $641M AUM
AG
Alibaba Group Causeway Bay, Hong Kong $653M AUM 16.11% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Brian C. Broderick's Q4 2014 Portfolio in Review

As of Q4 2014, Brian C. Broderick held 119 positions worth $236M, up 5% from $225M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q4 2014 filing shows 6 new, 45 increased, 36 reduced and 15 closed positions. Its largest new stake was CDK Global, Inc.: 25,869 shares worth $1.05M. The largest sale was GSK, an estimated $2.61M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q4 2014 buy was CDK Global, Inc.: 25,869 shares worth $1.05M.
  • Brian C. Broderick added most to Abbott in Q4 2014, an estimated $605K increase.
  • Brian C. Broderick's biggest Q4 2014 reduction was GSK, cutting an estimated $2.61M.
  • Brian C. Broderick fully exited Vanguard FTSE Emerging Markets ETF in Q4 2014, selling an estimated $354K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $236M portfolio in Q4 2014.
  • Brian C. Broderick opened 6 new positions and closed 15 in Q4 2014.
  • Brian C. Broderick's portfolio value rose 5% quarter-over-quarter to $236M.

Based on Brian C. Broderick's 13F filing for Q4 2014, filed 13 Feb 2015.